Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Roll Call

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Daily Mirror

Biogen Skids As Analysts Debate Uptake For Newly Approved Alzheimer's Drug

Biogen stock skidded Friday after the Food and Drug Administration fully approved its Alzheimer's treatment, Leqembi.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

AbbVie (ABBV) vs. Pfizer (PFE) - Which Pharma Stock Comes out on Top?

With the growing prevalence of chronic conditions, an aging population, widespread adoption of digital technologies, and several R&D efforts, the pharmaceutical industry is poised for exponential growth and expansion. So, let’s compare leading pharma stocks AbbVie (ABBV) and Pfizer (PFE) to identify which is a better investment now. Keep reading….

StockNews.com

Test approved to detect preeclampsia, leading cause of US maternal deaths

FDA approves new test, which has been widely celebrated as a small victory in the fight to make childbirth safer in the US

The Guardian - US

The plan to dodge another tripledemic

Vaccines to stave off the flu, a new COVID variant and now, respiratory syncytial virus could help avert another tripledemic this fall. Unless the public is too crisis-fatigued to care.

Axios

As low-nicotine cigarettes hit the market, anti-smoking groups press for wider standard

The idea seems simple enough.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Is aspartame actually that harmful?

"While reports like these can understandably be worrying, there's no reason to panic at this stage"

Salon

A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.

Inverse

Aspartame: popular sweetener could be classified as a possible carcinogen by WHO – but there's no cause for panic

According to reports, the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), is set to declare the artificial sweetener aspartame as “possibly carcinogenic to humans”.

The Conversation

Exosome Therapy Is Ushering in the Next Generation of Skin and Hair Rejuvenation

“Think of exosomes as the body’s own information superhighway.”

Marie Claire

Apple AirPods may double as hearing aids in the future — you'll finally stop saying 'huh?!'

Apple is reportedly working on adding several new game-changing health perks to the AirPods, including hearing-enhancing features and other cool additions.

Laptop

Abortion access could continue to change in year 2 after the overturn of Roe v. Wade

It's already harder to get an abortion in many places and access is likely to be limited more with the passage of new laws.

WEKU

New bill to ban toxic chemicals in food

"Things like this aren’t partisan. They’re common sense," said former governor Arnold Schwarzenegger

Salon

Get all your
news in one place.

100’s of premium titles.
One news app.

Apple's AirPods could become HearPods

Apple's earbuds could deliver better health tracking and help your hearing too

The Independent UK

Australia is the first nation to let patients with depression or PTSD be prescribed psychedelics

Australia is now the first country to allow psychiatrists to prescribe certain psychedelic substances to patients with depression or post-traumatic stress disorder

Tribune News Service

Humira, the world’s top-selling drug, faces an upcoming test from low cost alternatives

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor.

Investors Business Daily

Stock Market Rebounds Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review

The market rally had a strong week, with the major indexes rebounding toward 2023 highs and many stocks flashing buy signals.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Madrigal Stock Pops As It Makes Inroads Into What Could Be A $160 Billion Market

Madrigal said Friday it plans to finish submitting its application for approval of a NASH treatment in July, and MDGL stock popped.

The Guardian - US

New report finds most US kale samples contain ‘disturbing’ levels of ‘forever chemicals’

PFAS was found in seven of eight samples bought at US stores, with organic kale containing higher levels of the toxic compounds

The Independent UK

Gene therapy for severe hemophilia is approved by FDA

U.S. health regulators have approved a gene therapy for the most common form of hemophilia

Investors Business Daily

Reata Surges 12% Over Three Days; CEO Reflects On The Tricky Path To Launch A First-Ever Drug

Reata CEO Warren Huff says Friedreich's ataxia is "the worst disease." Now, RETA stock investors are watching the long-awaited drug launch.

The Independent UK

Biden's brother says the president is 'very open-minded' about psychedelics for medical treatment

President Joe Biden’s youngest brother said in a radio interview that the president has been “very open-minded” in conversations the two have had about the benefits of psychedelics as a form of medical treatment

Investors Business Daily

Reata Nears Breakout After Snagging FDA Blessing To Launch Its Friedreich's Ataxia Drug

Reata Pharmaceuticals won the FDA's blessing to launch its Friedreich's ataxia drug, and RETA stock surged Wednesday.

Tribune News Service

E-cigs are still flooding the US, addicting teens with higher nicotine doses

When the FDA first asserted the authority to regulate e-cigarettes in 2016, many people assumed the agency would quickly get rid of vapes with flavors like cotton candy, gummy bears, and Froot Loops that appeal to kids.

1 … 64 65 66 67

People

Arnold Schwarzenegger

624 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

the World Health Organization

391 stories

Snowflake

360 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.